Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (111-120 of 275) with videos related to

Pageof 28
Sort By:
Assay and Drug Development Technologies|December 23, 2015
Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer TherapyDaniel L Gustafson, Jared S Fowles, Kristen C Brown, et al.
Stem Cells (Dayton, Ohio)|December 21, 2013
A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitorsGarrett M Dancik, Charles R Owens, Kenneth A Iczkowski, et al.
Cancers|October 13, 2021
Targetable Pathways in Advanced Bladder Cancer: FGFR SignalingJin-Fen Xiao, Andrew W Caliri, Jason E Duex, et al.
Cancer Research|February 18, 2010
The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancerSteven C Smith, Alexander S Baras, Jae K Lee, et al.
Molecular Cancer Therapeutics|June 19, 2007
Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomesMikael Herlevsen, Gary Oxford, Charles R Owens, et al.
The Journal of Urology|December 14, 2004
Brachytherapy of prostate cancer after colectomy for colorectal cancer: pilot experiencePanos G Koutrouvelis, Dan Theodorescu, Stuart Katz, et al.
Cancer|February 25, 2003
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapyNicole L Miller, Eric A Bissonette, Robert Bahnson, et al.
Proteomics|September 21, 2007
Statistical identification of differentially labeled peptides from liquid chromatography tandem mass spectrometryHyungjun Cho, David M Smalley, Dan Theodorescu, et al.
The American Journal of Pathology|October 10, 2009
Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapyCourtney Pollard, Matt Nitz, Alex Baras, et al.
The Prostate|October 9, 2007
Rap2 regulates androgen sensitivity in human prostate cancer cellsDora Bigler, Daniel Gioeli, Mark R Conaway, et al.
Pageof 28

Showing results (111-120 of 275) with videos related to

Sort By:
Pageof 28
Assay and Drug Development Technologies|December 23, 2015
Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer TherapyDaniel L Gustafson, Jared S Fowles, Kristen C Brown, et al.
Stem Cells (Dayton, Ohio)|December 21, 2013
A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitorsGarrett M Dancik, Charles R Owens, Kenneth A Iczkowski, et al.
Cancers|October 13, 2021
Targetable Pathways in Advanced Bladder Cancer: FGFR SignalingJin-Fen Xiao, Andrew W Caliri, Jason E Duex, et al.
Cancer Research|February 18, 2010
The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancerSteven C Smith, Alexander S Baras, Jae K Lee, et al.
Molecular Cancer Therapeutics|June 19, 2007
Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomesMikael Herlevsen, Gary Oxford, Charles R Owens, et al.
The Journal of Urology|December 14, 2004
Brachytherapy of prostate cancer after colectomy for colorectal cancer: pilot experiencePanos G Koutrouvelis, Dan Theodorescu, Stuart Katz, et al.
Cancer|February 25, 2003
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapyNicole L Miller, Eric A Bissonette, Robert Bahnson, et al.
Proteomics|September 21, 2007
Statistical identification of differentially labeled peptides from liquid chromatography tandem mass spectrometryHyungjun Cho, David M Smalley, Dan Theodorescu, et al.
The American Journal of Pathology|October 10, 2009
Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapyCourtney Pollard, Matt Nitz, Alex Baras, et al.
The Prostate|October 9, 2007
Rap2 regulates androgen sensitivity in human prostate cancer cellsDora Bigler, Daniel Gioeli, Mark R Conaway, et al.
Pageof 28